Split-face comparative trial of 785-nm picosecond neodymium:yttrium-aluminum-garnet laser and precision cryotherapy combination treatment for facial benign pigmented lesions

Dermatol Ther. 2022 Feb;35(2):e15240. doi: 10.1111/dth.15240. Epub 2021 Dec 8.

Abstract

Cryotherapy (or cryosurgery) has been performed to treat various skin lesions in the field of dermatology; however, to the best of our knowledge, no study has investigated its efficacy and safety for benign pigmented lesions. Therefore, we conducted a split-face study to evaluate the efficacy and safety of cryotherapy in the treatment of benign pigmented lesions. A total of five subjects were included. Picosecond laser therapy was performed to treat the whole face and cryotherapy for half the face. Four weeks after completing the treatment sessions, patients showed more clinical improvement on the laser and cryotherapy combination treatment side than on the laser-only side, with no adverse events. Our study demonstrated that cryotherapy is a potential adjuvant therapeutic modality for benign pigmented lesions.

Keywords: cryosurgery; cryotherapy; laser; pigmentation.

Publication types

  • Clinical Trial

MeSH terms

  • Aluminum
  • Cryotherapy / adverse effects
  • Humans
  • Lasers, Solid-State* / therapeutic use
  • Neodymium*
  • Treatment Outcome
  • Yttrium

Substances

  • yttrium-aluminum-garnet
  • Neodymium
  • Yttrium
  • Aluminum